IRCT20220516054874N4招募中2 期
Evaluation of the effectivness of Montelukast on the hs-CRP level in patients with non ST-elevation myocardial infarction
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 68
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •Patients with non-ST-elevation MI according to the American College of Heart criteria
- •Consent to admission to the study
- •Age more than 18 years old
- •No kidney failure under hemodialysis
- •No kidney failure and GFR<30
- •No thrombocytopenia
- •No severe liver failure with liver enzymes three times more than normal
- •No treatment with corticosteroids or immunosuppressive drugs
- •No treatment with diltiazem or verapamil
- •No history or prone to suicide
- •No previous treatment with Montelukast
排除标准
- •Lack of consent to continue the study
研究者
相似试验
尚未招募
3 期
The effect of Montelukast in the treatment of cystitisCystitisCystitis.IRCT20220203053919N1Arak University of Medical Sciences56
已完成
3 期
Therapeutic effect of Montelukast in patients with oral lichen planusLichen Planusichen Planus.IRCT2012110811389N2Vice Chancellor for Research , Hamedan University of Medical Sciences200
招募中
2 期
The effect of Montelukast on respiratory complications detected in patients with multiple trauma and lung injuryPulmonary embolismIRCT20190719044270N1Bagheiat-allah University of Medical Sciences60
进行中（未招募）
1 期
Efficacy and safety of Montelukast as add on treatment to the novel coronavirus pneumonia (COVID-19)EUCTR2020-001747-21-PTInstituto de Saúde Pública Universidade Porto160
招募中
3 期
The effect of Montelukast on COVID 19 disease activityIRCT20181208041886N3Abidi Pharmaceutical company60